APAC Healthcare Weekly (May 24)– Hansoh, Junshi Bio, Daiichi Sankyo, SanBio, Hanmi Pharm, Yuhan Corp
Hansoh’s HS-10504 tablets secured BTD in China. Junshi Bio secured 13th indication approval for toripalimab. Daiichi Sanyo’s Enhertu and Datroway...
88 Views
Mankind Pharma Lock-Up - A US$1.1bn+ Lockup Release
The two pre-IPO investors have launched a block to sell around US$591m worth of Mankind Pharma shares. Since the lockup on the shares expired not...
889 Views
Alkem Laboratories: Occlutech M&A to Support Medtech Aspiration. Maintain ADD
Alkem MedTech (a w.o.s of Alkem Labs) to acquire 51-55% stake in Occlutech Holding AG (Occlutech) for cash consideration of Euro 99.4 mn, implying...
186 Views
Pharmaceuticals: IPM: 11% growth in Mar-26, 10% in FY26
Growth was led by CVS, anti-diabetes, pain, VMN, and oncology segments, while growth in anti-infective and respiratory was below IPM growth
126 Views
IPM Pharma Pulse March-25: Driven by Semaglutide Generics; Low Single Digit Growth Outlook for FY27
​IPM sees 11% YoY growth in Mar 2026, driven by Semaglutide generics and GLP-1 market surge. Jan Aushadhi's expansion poses challenge to branded...
437 Views